Gelita has hosted a webinar to reveal the novel role of collagen and its new product IMMUPEPT in immune health.
Alongside with the Collagen Research Institute (CRI), both organisations shared new scientific evidence highlighting the role of collagen-rich tissues in supporting a well-functioning immune system. Scientists and health professionals have recognised how these tissues, namely skin, bones, as well as the whole-body extracellular matrix, play a role in the immune system. Skin, for example, is found the body’s most important barrier, and the first line of defense in protecting immune health. Bones are collagen-rich, and all cells of the immune system derive from the bone marrow. Bone cells also regulate the activity of immune cells, and vice-versa, in a bone-immune system interplay. Less known is the role of the whole-body extracellular matrix, also a key component of the dermal layer of the skin, where most immune cells live, and where several immune responses take place.
Gelita’s latest edition to its portfolio of Bioactive Collagen Peptides is IMMUPEPT, which offers the advantages of collagen peptides to the immune health category. IMMUPEPT features optimised peptide profiles for stimulation of the collagen-rich connective tissues involved in the immune response, adding a more holistic approach to immune support.
IMMUPEPT 25 is designed to optimally stimulate keratinocytes and fibroblasts. Furthermore, IMMUPEPT 50 offers an added benefit with specific peptides that stimulate the specific bone-remodelling cells that maintain healthy bones, important for those bone-immune system interplay.
In addition to an understanding of the role of collagen-rich tissues in immune health, Gelita also shared new data from the CRI. These new trials indicate an immune modulating effect from the Bioactive Collagen Peptides in IMMUPEPT, showing potential to regulate three key factors for an effective immune response, such as reduced inflammation, reduced tissue damage, and reduced oxidative stress.
As global health and nutrition companies are being called upon to respond to the growing consumer desire for immunity, the launch of IMMUPEPT reaffirms Gelita’s commitment to advancing the understanding of how specific Bioactive Collagen Peptides benefit immune health in a holistic way.